While NF-κB blockade leads to a significant decrease in cell viability due to apoptosis, we believe that regulation of the NF-κB pathway may be a potent therapeutic target in platinum-resistant bladder cancer. Here, NFKB1 is linked to urinary bladder carcinoma.